Dust in IJmond contains many PAHs and metals In Wijk aan Zee, Beverwijk, Velsen-Noord and IJmuiden, more polycyclic aromatic hydrocarbons (PAHs) and metals were found in the deposition of dust than outside the IJmond region.
RIVM involvement in UN/EU missions RIVM-experts from the Environmental Assessment Unit (EAU) have undertaken two missions involving an emergency situation in the Solomon Islands and an environmental assessment in Georgia.
Clinical condition Dutch MERS patients improving The two patients who were diagnosed last week with the MERS coronavirus are now on the mend.
The MERS-coronavirus in the Netherlands As of 13 May 2014, RIVM and Erasmus MC have diagnosed the MERS coronavirus in two Dutch people. The patients are related and were infected during a joint journey to Saudi Arabia.
New assessment framework for leachate water from landfill sites RIVM and ECN have developed an innovative assessment framework for testing the environmental effects on soil and groundwater of leachate water from sustainable landfill sites.
HFC greenhouse gases accumulate in refrigerators and air conditioners Hydrofluorocarbons (HFCs) are potent greenhouse gases used in refrigerators and air conditioners and are released primarily at the end of the life-span of these products.
RIVM participating in European Joint Action on Chronic Diseases The coming year RIVM is going to be collecting good examples of interventions for the prevention of chronic diseases such as cardiovascular disease and type 2 diabetes.
Mental care still the most expensive of all In 2011, 19.6 billion euros was spent on the treatment of mental disorders. This amounted to 22% of the total expenditure on health and welfare during that year.
Risks of eHealth technology RIVM and Nictiz have made an overview of the risks that eHealth applications may entail and how these risks can be controlled.
Key organisations unite to improve benefit and risk assessments of vaccines Leading organisations have joined forces to launch a unique project that will pave the way for a pan-European framework for rapidly assessing and communicating the benefits and risks of vaccines.